$Moderna (MRNA.US)$ Shares of moderna (MRNA) rose more than 10% shortly after 6 p.m. ET, after the company announced a deal to supply the US government with 100 million doses of its Covid-19 vaccine candidate currently in late-stage human trials. This is a big deal.

$Remark Holdings (MARK.US)$
Schools reopening under discussion since COVID-19 numbers are still high. Flu season around the corner. Schools and other reopening sectors will need to exhaust all exhaust, including Remark's AI thermal kits.